RAPT Therapeutics Reports Fourth Quarter 2019 Financial Results and Provides Business Update Portfolio News / By admin March 30, 2020 RAPT Therapeutics Reports Fourth Quarter 2019 Financial Results and Provides Business Update Read More »
Surrozen Announces Publication of Antibody Platform Technology in Cell Chemical Biology Portfolio News / By admin March 30, 2020 Surrozen Announces Publication of Antibody Platform Technology in Cell Chemical Biology Read More »
Kallyope Inc. Announces $112M Series C Financing to Support First Clinical Trials and Advance Portfolio of Programs Targeting the Gut-Brain Axis Portfolio News / By admin March 25, 2020 Kallyope Inc. Announces $112M Series C Financing to Support First Clinical Trials and Advance Portfolio of Programs Targeting the Gut-Brain Axis Read More »
NGM Bio Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights Portfolio News / By admin March 17, 2020 NGM Bio Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights Read More »
Circle Pharma raises $45 Million in Series B Financing Portfolio News / By admin March 17, 2020 Circle Pharma raises $45 Million in Series B Financing Read More »
Nurix Therapeutics Closes $120 Million Financing to Advance Targeted Protein Modulation Drug Pipeline Portfolio News / By admin March 12, 2020 Nurix Therapeutics Closes $120 Million Financing to Advance Targeted Protein Modulation Drug Pipeline Read More »
Gritstone Oncology Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights Portfolio News / By admin March 11, 2020 Gritstone Oncology Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights Read More »
Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2019 Financial Results Portfolio News / By admin March 10, 2020 Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2019 Financial Results Read More »
Revolution Medicines’ New Clinical Trial Exploring Investigational SHP2 Inhibitor RMC-4630 in Combination with an ERK Inhibitor Announced by Netherlands Cancer Institute Portfolio News / By admin March 9, 2020 Revolution Medicines’ New Clinical Trial Exploring Investigational SHP2 Inhibitor RMC-4630 in Combination with an ERK Inhibitor Announced by Netherlands Cancer Institute Read More »
Aetna Wun Trombley, Ph.D. to Step Down as President and Chief Operating Officer of NGM Bio to Assume Chief Executive Officer Role at Undisclosed Privately Held Company Portfolio News / By admin March 9, 2020 Aetna Wun Trombley, Ph.D. to Step Down as President and Chief Operating Officer of NGM Bio to Assume Chief Executive Officer Role at Undisclosed Privately Held Company Read More »
